A Bcl-2-dependent molecular timer regulates the lifespan and immunogenicity of dendritic cells
10.1038/ni1071
Crossref journal-article
Springer Science and Business Media LLC
Nature Immunology (297)
Bibliography

Hou, W.-S., & Van Parijs, L. (2004). A Bcl-2-dependent molecular timer regulates the lifespan and immunogenicity of dendritic cells. Nature Immunology, 5(6), 583–589.

Authors 2
  1. Wu-Shiun Hou (first)
  2. Luk Van Parijs (additional)
References 36 Referenced 152
  1. Banchereau, J. & Steinman, R.M. Dendritic cells and the control of immunity. Nature 392, 245–252 (1998). (10.1038/32588) / Nature by J Banchereau (1998)
  2. Steinman, R.M., Hawiger, D. & Nussenzweig, M.C. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21, 685–711 (2003). (10.1146/annurev.immunol.21.120601.141040) / Annu. Rev. Immunol. by RM Steinman (2003)
  3. Ingulli, E., Mondino, A., Khoruts, A. & Jenkins, M.K. In vivo detection of dendritic cell antigen presentation to CD4+ T cells. J. Exp. Med. 185, 2133–2141 (1997). (10.1084/jem.185.12.2133) / J. Exp. Med. by E Ingulli (1997)
  4. Josien, R. et al. TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo. J. Exp. Med. 191, 495–502 (2000). (10.1084/jem.191.3.495) / J. Exp. Med. by R Josien (2000)
  5. Nopora, A. & Brocker, T. Bcl-2 controls dendritic cell longevity in vivo. J. Immunol. 169, 3006–3014 (2002). (10.4049/jimmunol.169.6.3006) / J. Immunol. by A Nopora (2002)
  6. Wang, J. et al. Inherited human caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell 98, 47–58 (1999). (10.1016/S0092-8674(00)80605-4) / Cell by J Wang (1999)
  7. Park, Y., Lee, S.W. & Sung, Y.C. Cutting edge: CpG DNA inhibits dendritic cell apoptosis by up-regulating cellular inhibitor of apoptosis proteins through the phosphatidylinositide-3′-OH kinase pathway. J. Immunol. 168, 5–8 (2002). (10.4049/jimmunol.168.1.5) / J. Immunol. by Y Park (2002)
  8. Rescigno, M., Martino, M., Sutherland, C.L., Gold, M.R. & Ricciardi-Castagnoli, P. Dendritic cell survival and maturation are regulated by different signaling pathways. J. Exp. Med. 188, 2175–2180 (1998). (10.1084/jem.188.11.2175) / J. Exp. Med. by M Rescigno (1998)
  9. Caux, C. et al. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180, 1263–1272 (1994). (10.1084/jem.180.4.1263) / J. Exp. Med. by C Caux (1994)
  10. Wong, B.R. et al. TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J. Exp. Med. 186, 2075–2080 (1997). (10.1084/jem.186.12.2075) / J. Exp. Med. by BR Wong (1997)
  11. Ouaaz, F., Arron, J., Zheng, Y., Choi, Y. & Beg, A.A. Dendritic cell development and survival require distinct NF-κB subunits. Immunity 16, 257–270 (2002). (10.1016/S1074-7613(02)00272-8) / Immunity by F Ouaaz (2002)
  12. Ardeshna, K.M., Pizzey, A.R., Devereux, S. & Khwaja, A. The PI3 kinase, p38 SAP kinase, and NF-κB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells. Blood 96, 1039–1046 (2000). (10.1182/blood.V96.3.1039) / Blood by KM Ardeshna (2000)
  13. Schwandner, R., Dziarski, R., Wesche, H., Rothe, M. & Kirschning, C.J. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J. Biol. Chem. 274, 17406–17409 (1999). (10.1074/jbc.274.25.17406) / J. Biol. Chem. by R Schwandner (1999)
  14. Kopp, E. & Medzhitov, R. Recognition of microbial infection by Toll-like receptors. Curr. Opin. Immunol. 15, 396–401 (2003). (10.1016/S0952-7915(03)00080-3) / Curr. Opin. Immunol. by E Kopp (2003)
  15. Takeda, K., Kaisho, T. & Akira, S. Toll-like receptors. Annu. Rev. Immunol. 21, 335–376 (2003). (10.1146/annurev.immunol.21.120601.141126) / Annu. Rev. Immunol. by K Takeda (2003)
  16. Hemmi, H. et al. A Toll-like receptor recognizes bacterial DNA. Nature 408, 740–745 (2000). (10.1038/35047123) / Nature by H Hemmi (2000)
  17. Grewal, I.S. & Flavell, R.A. CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. 16, 111–135 (1998). (10.1146/annurev.immunol.16.1.111) / Annu. Rev. Immunol. by IS Grewal (1998)
  18. Motoyama, N. et al. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 267, 1506–1510 (1995). (10.1126/science.7878471) / Science by N Motoyama (1995)
  19. Wagner, K.U. et al. Conditional deletion of the Bcl-x gene from erythroid cells results in hemolytic anemia and profound splenomegaly. Development 127, 4949–4958 (2000). (10.1242/dev.127.22.4949) / Development by KU Wagner (2000)
  20. Zhong, L., Granelli-Piperno, A., Choi, Y. & Steinman, R.M. Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells. Eur. J. Immunol. 29, 964–972 (1999). (10.1002/(SICI)1521-4141(199903)29:03<964::AID-IMMU964>3.0.CO;2-P) / Eur. J. Immunol. by L Zhong (1999)
  21. Bouillet, P. et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286, 1735–1738 (1999). (10.1126/science.286.5445.1735) / Science by P Bouillet (1999)
  22. Bouillet, P., Cory, S., Zhang, L.C., Strasser, A. & Adams, J.M. Degenerative disorders caused by Bcl-2 deficiency prevented by loss of its BH3-only antagonist Bim. Dev. Cell. 1, 645–653 (2001). (10.1016/S1534-5807(01)00083-1) / Dev. Cell. by P Bouillet (2001)
  23. Barnden, M.J., Allison, J., Heath, W.R. & Carbone, F.R. Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements. Immunol. Cell. Biol. 76, 34–40 (1998). (10.1046/j.1440-1711.1998.00709.x) / Immunol. Cell. Biol. by MJ Barnden (1998)
  24. Veis, D.J., Sorenson, C.M., Shutter, J.R. & Korsmeyer, S.J. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75, 229–240 (1993). (10.1016/0092-8674(93)80065-M) / Cell by DJ Veis (1993)
  25. Kleindienst, P. & Brocker, T. Endogenous dendritic cells are required for amplification of T cell responses induced by dendritic cell vaccines in vivo. J. Immunol. 170, 2817–2823 (2003). (10.4049/jimmunol.170.6.2817) / J. Immunol. by P Kleindienst (2003)
  26. Jung, S. et al. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity 17, 211–220 (2002). (10.1016/S1074-7613(02)00365-5) / Immunity by S Jung (2002)
  27. Klinman, D.M. CpG DNA as a vaccine adjuvant. Expert Rev. Vaccines 2, 305–315 (2003). (10.1586/14760584.2.2.305) / Expert Rev. Vaccines by DM Klinman (2003)
  28. Miga, A.J. et al. Dendritic cell longevity and T cell persistence is controlled by CD154-CD40 interactions. Eur. J. Immunol. 31, 959–965 (2001). (10.1002/1521-4141(200103)31:3<959::AID-IMMU959>3.0.CO;2-A) / Eur. J. Immunol. by AJ Miga (2001)
  29. De Smedt, T. et al. Antigen-specific T lymphocytes regulate lipopolysaccharide-induced apoptosis of dendritic cells in vivo. J. Immunol. 161, 4476–4479 (1998). (10.4049/jimmunol.161.9.4476) / J. Immunol. by T De Smedt (1998)
  30. Leadbetter, E.A. et al. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416, 603–607 (2002). (10.1038/416603a) / Nature by EA Leadbetter (2002)
  31. Mombaerts, P. et al. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68, 869–877 (1992). (10.1016/0092-8674(92)90030-G) / Cell by P Mombaerts (1992)
  32. Michaelidis, T.M. et al. Inactivation of bcl-2 results in progressive degeneration of motoneurons, sympathetic and sensory neurons during early postnatal development. Neuron 17, 75–89 (1996). (10.1016/S0896-6273(00)80282-2) / Neuron by TM Michaelidis (1996)
  33. Inaba, K. et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176, 1693–1702 (1992). (10.1084/jem.176.6.1693) / J. Exp. Med. by K Inaba (1992)
  34. Van Parijs, L. et al. Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death. Immunity 11, 281–288 (1999). (10.1016/S1074-7613(00)80103-X) / Immunity by L Van Parijs (1999)
  35. Kelly, E., Won, A., Refaeli, Y. & Van Parijs, L. IL-2 and related cytokines can promote T cell survival by activating AKT. J. Immunol. 168, 597–603 (2002). (10.4049/jimmunol.168.2.597) / J. Immunol. by E Kelly (2002)
  36. Mintern, J. et al. The use of carboxyfluorescein diacetate succinimidyl ester to determine the site, duration and cell type responsible for antigen presentation in vivo. Immunol. Cell. Biol. 77, 539–543 (1999). (10.1046/j.1440-1711.1999.00868.x) / Immunol. Cell. Biol. by J Mintern (1999)
Dates
Type When
Created 21 years, 3 months ago (May 9, 2004, 1:58 p.m.)
Deposited 2 years, 3 months ago (May 18, 2023, 6:37 p.m.)
Indexed 3 weeks, 1 day ago (Aug. 6, 2025, 8:57 a.m.)
Issued 21 years, 3 months ago (May 9, 2004)
Published 21 years, 3 months ago (May 9, 2004)
Published Online 21 years, 3 months ago (May 9, 2004)
Published Print 21 years, 2 months ago (June 1, 2004)
Funders 0

None

@article{Hou_2004, title={A Bcl-2-dependent molecular timer regulates the lifespan and immunogenicity of dendritic cells}, volume={5}, ISSN={1529-2916}, url={http://dx.doi.org/10.1038/ni1071}, DOI={10.1038/ni1071}, number={6}, journal={Nature Immunology}, publisher={Springer Science and Business Media LLC}, author={Hou, Wu-Shiun and Van Parijs, Luk}, year={2004}, month=may, pages={583–589} }